Independent Laboratory Verification

Certificate of Analysis & Batch Verification

Every synthesis lot manufactured for LC Peptides undergoes dual-stage High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (LC-MS) validation to guarantee greater than 99.0% research purity.

LC PEPTIDES PORTAL
Batch Verification
Enter the exact batch identification number and authorization code to retrieve authenticated test reports.
ISO/IEC 17025 Standard

Found on the secondary vial label

Secure digital copy will be sent here

Printed alongside the QR code

Independent 3rd-party laboratory HPLC & LC-MS verification

Scientific Standards

Analytical Testing Methodology

Our dual-testing protocol verifies both structural molecular identity and quantitative chemical purity before any compound is released.

Threshold: ≥ 99.0%
High-Performance Liquid Chromatography (HPLC)
Quantitative chromatographic purity assessment and trace impurity resolution.

Reverse-phase HPLC isolates the target peptide molecule from truncated peptide sequences, oxidation byproducts, and residual synthesis adducts.

Stationary Phase:C18 4.6×250mm, 5μm
UV Detection:214 nm & 220 nm
Accuracy: ± 1.0 Da
Mass Spectrometry (LC-MS) Identification
Exact molecular mass-to-charge (m/z) structural confirmation.

Electrospray Ionization Mass Spectrometry (ESI-MS) confirms that the primary amino acid sequence matches the theoretical molecular weight exactly.

Ionization Mode:Positive ESI (+)
Mass Tolerance:< 0.5 Da variance
Simulated Analytical Readout
Chromatogram & Spectral Visualization
Interactive readout demonstrating typical high-purity single-peak resolution on Lot COA-2606290614.
Resolved Purity: 99.99%
Target: NAD+ (Net Content: 1074.65 mg)
Retention Time (Rt): 4.02 minArea: 99.42%
Flow: 1.0 mL/min

COA Records

Current Certificate Data

COA-2606290xxxPurity: 99.99%

NAD+ 1000mg

Specification: 1074.65mg / vial

Synthesis Date:2026-07-01
Test Methods:HPLC-UV / LC-MS
Net Content:1074.65mg / vial
Appearance:White Lyophilized Powder
COA-26062xxxPurity: 99.81%

GHK-Cu 100mg

Specification: 115.19mg / vial

Synthesis Date:2026-07-01
Test Methods:HPLC-UV / LC-MS
Net Content:115.19mg / vial
Appearance:Blue Lyophilized Powder
COA-2606090xxxPurity: 99.87%

Retatrutide 20mg

Specification: 22.21mg / vial

Synthesis Date:2026-06-11
Test Methods:HPLC-UV / LC-MS
Net Content:22.21mg / vial
Appearance:White Lyophilized Powder
COA-2606090xxxPurity: 99.88%

Retatrutide 30mg

Specification: 31.49mg / vial

Synthesis Date:2026-06-11
Test Methods:HPLC-UV / LC-MS
Net Content:31.49mg / vial
Appearance:White Lyophilized Powder
COA-2605010xxxPurity: 99.93%

Retatrutide 10mg

Specification: 10.34mg / vial

Synthesis Date:2026-05-03
Test Methods:HPLC-UV / LC-MS
Net Content:10.34mg / vial
Appearance:White Lyophilized Powder
Strict Regulatory NoticeRUO (Research Use Only)

All compounds, formulations, and peptides distributed are strictly intended for research purposes only.

Supplying high-purity research-grade peptides, GLP compounds, and custom analytical synthesis for scientific institutions and clinical laboratories nationwide.

HPLC 99%+ VerifiedCold-Chain Secure

Navigation & Shop

Policies

Laboratory Support

© 2026 LC Peptides. All rights reserved. For in-vitro research use only.

Terms & Conditions•Privacy Policy•Quality Assurance